Thursday, Apr 18, 2024 | Last Update : 07:04 PM IST

triple HIV drug

Gilead triple HIV drug finds US FDA approval

However, rival ViiV Healthcare, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV’s dolutegravir.

08 Feb 2018 9:54 AM

ADVERTISEMENT
ADVERTISEMENT